J G Kelton, J Hirsh. Show Affiliations »
Abstract
Mesh: See more » 4-Hydroxycoumarins/adverse effects4-Hydroxycoumarins/therapeutic useAspirin/adverse effectsAspirin/therapeutic useDextrans/adverse effectsDextrans/therapeutic useDipyridamole/adverse effectsDipyridamole/therapeutic useDose-Response Relationship, DrugFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useHemorrhage/chemically inducedHeparin/adverse effectsHeparin/therapeutic useHumansMyocardial Infarction/drug therapyRiskStreptodornase and Streptokinase/adverse effectsStreptodornase and Streptokinase/therapeutic useSulfinpyrazone/adverse effectsSulfinpyrazone/therapeutic useThrombocytopenia/chemically inducedThrombosis/drug therapy
Substances: See more » 4-HydroxycoumarinsDextransFibrinolytic AgentsDipyridamoleHeparinStreptodornase and StreptokinaseAspirinSulfinpyrazone
Year: 1980 PMID: 6160618
Source DB: PubMed Journal: Semin Hematol ISSN: 0037-1963 Impact factor: 3.851